THE PROGNOSTIC VALUE OF BASELINE PSA BLOOD IN THE TREATMENT OF PROSTATE CANCER
The role of the level of prostate specific antigen ( PSA) before initial therapy discusses widely as a prognostic factor in the treatment of prostate cancer (PC ). Despite the fact that many of the questions on the diagnostic and prognostic value of PSA unclear, and new markers of prostate dis...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bashkir State Medical University
2017-02-01
|
| Series: | Креативная хирургия и онкология |
| Subjects: | |
| Online Access: | https://www.surgonco.ru/jour/article/view/169 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The role of the level of prostate specific antigen ( PSA) before initial therapy discusses widely as a prognostic factor in the treatment of prostate cancer (PC ). Despite the fact that many of the questions on the diagnostic and prognostic value of PSA unclear, and new markers of prostate diseases are being introduced with increasing frequency , we assume that the PSA will continue to be one of the main methods of screening and monitoring of patients with prostate cancer, because of its high diagnostic value due to tissue specificity. Using the initial PSA level and Gleason score improves the predictive value significantly. This article presents the results of a retrospective analysis of 307 patients completed the treatment of PC. The effect of baseline PSA level and Gleason score on the choice of treatment , the effectiveness of hormone deprivation and overall survival are evaluated. |
|---|---|
| ISSN: | 2076-3093 2307-0501 |